BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner

• Ken S. Lau,

  Affiliations Molecular Pathology Unit, Center for Cancer Research and Center for Systems Biology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, Department of Biological Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
• Tinghu Zhang,

  Affiliation Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Krystle R. Kendall,

  Affiliation Molecular Pathology Unit, Center for Cancer Research and Center for Systems Biology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• Douglas Lauffenburger,

  Affiliation Department of Biological Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
• Nathanael S. Gray,

  Affiliation Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Kevin M. Haigis

  * E-mail: khaigis@partners.org

  Affiliation Molecular Pathology Unit, Center for Cancer Research and Center for Systems Biology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯